May 21, 2024
https://blogs.oncolink.org/2021/02/rare-disease-day-raising-awareness-for-rare-cancers/

Yearly on the final day of February, the world acknowledges uncommon ailments—a day now often called Rare Disease Day. Uncommon ailments have an effect on roughly 25 million to 30 million individuals in the US every year. The aim of Uncommon Illness Day is to coach the general public and lift consciousness amongst decision-makers concerning the impression of uncommon ailments on sufferers’ lives. Determination-makers embrace those that make strides advancing crucial analysis: policymakers, trade representatives, well being professionals, advocates, and extra. Via their assist, extra motion could be taken to fight uncommon ailments.

In response to the National Cancer Institute (NCI), about one-quarter of all most cancers deaths every year are brought on by uncommon cancers. And, the truth is, most sorts of most cancers are thought-about uncommon. Sadly, uncommon cancers are tougher to deal with than frequent cancers—and they’re harder to analysis due to the restricted variety of sufferers. Different points associated to uncommon cancers embrace lack of expertise amongst physicians about uncommon cancers, and issue discovering consultants who can reply questions.

Regardless of these obstacles, researchers do discover methods to review uncommon cancers and develop higher prevention methods and coverings. For instance, in June 2020 the results of the primary randomized medical trial for inoperable anal most cancers decided the perfect chemotherapy routine for sufferers. Earlier than the trial, the standard strategy for these sufferers was palliative care or care that focuses on offering reduction from ache and different signs. Now, researchers are constructing on their findings in a phase III clinical trial that can add an immunotherapy drug to chemotherapy to hopefully enhance affected person care even additional.

A medical trial could also be a sensible choice for somebody identified with a uncommon most cancers, although sufferers ought to all the time talk about therapy choices with their physician first. Details about most cancers medical trials is on the market in OncoLink’s Clinical Trials section, which additionally features a useful clinical trial matching service. Examples of uncommon most cancers medical trials which are at the moment out there embrace:

  • Neuroendocrine tumors (NETs)
  • Penile most cancers
  • Mantle cell lymphoma

In the US, NETs happen in about 12,000 individuals every year; these tumors can seem in any a part of the physique, however usually develop within the lungs, gastrointestinal tract, or pancreas. Mantle cell lymphoma, a uncommon sort of non-Hodgkin lymphoma, impacts about 4,200 individuals yearly whereas penile most cancers impacts simply 2,200 individuals every year. With a view to be thought-about “uncommon,” a most cancers can solely happen in 40,000 individuals or fewer per yr within the US. Nevertheless, when taken collectively, uncommon cancers are literally extra frequent than breast, colon, lung, or prostate most cancers. And, individuals going through uncommon cancers are simply as in want of higher prevention, therapies, and cures as these going through frequent cancers.

For uncommon most cancers assets or assist, go to NORD, the National Cancer Institute or Cancer.Net. Take into account becoming a member of the motion on February 28 by sharing your expertise with uncommon ailments on social media utilizing the hashtag #RareDiseaseDay. As consciousness of uncommon ailments—like uncommon most cancers—will increase, so do enhancements in affected person care and outcomes.


Katie Heller, MA, is a visitor author who works in advertising and medical training at ECOG-ACRIN Most cancers Analysis Group. Beforehand, she held roles on the American Society of Scientific Oncology and their basis, Conquer Most cancers. She has almost a decade of expertise in oncology and well being care communications. Katie obtained a Bachelor’s Diploma in English from Loyola College Maryland and a Grasp’s Diploma in Media, Tradition, and Communication from New York College.